26.12.2016 Views

2016–2017 2016–2017

2016-2017-graduate-catalog

2016-2017-graduate-catalog

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

COURSE DESCRIPTIONS<br />

BSBD 641 Biosecurity and Bioterrorism (3)<br />

A review of bioterrorism, biosecurity, and government biodefense<br />

strategy, including the history and science of biological<br />

agents in agriculture and society. Discussion covers surveillance;<br />

public health preparedness; response; and recovery at<br />

the community, state, and federal government levels. Various<br />

aspects of the law, including the Posse Comitatus Act and federal<br />

and state quarantine powers, are introduced. The mental<br />

health consequences of bioterrorism are also discussed. A case<br />

study of a hypothetical biological attack is analyzed in detail.<br />

BSBD 642 Advanced Biosecurity and Bioterrorism (3)<br />

Prerequisite: BIOT 681 or BSBD 641. A thorough examination<br />

of special and advanced topics in bioterroism and biosecurity<br />

issues. Topics include the hidden biological warfare programs<br />

of the 20th century; advances in biotechnology and molecular<br />

microbiology and the dilemma of dual use research; domestic<br />

and foreign terrorist groups, including rogue states; state-ofthe-art<br />

microbial forensics; ethics and civil rights; and current<br />

trends in policy development, consequence management, and<br />

public health responses to new threats to homeland security.<br />

Discussion also addresses special topics of the students’ choice.<br />

Future challenges in biosecurity are also discussed as part of a<br />

comprehensive bioterrorism exercise and the analysis of case<br />

studies of hypothetical threats.<br />

BSBD 643 Strategies for Interagency Cooperation, Verification,<br />

and Global Countermeasures in Biodefense (6)<br />

An in-depth study of the verification procedures used in global<br />

countermeasures and strategies. Global biosecurity and<br />

oversight are examined using real-world examples. Discussion<br />

covers the epidemiology of emerging infectious diseases as they<br />

relate to defense against threats from nonconventional sources.<br />

Topics also include the evolution and current status of the<br />

Biological Weapons Convention; the integration of responses<br />

from local, state, and multiple federal agencies; and other challenges<br />

facing public health departments, including the potential<br />

economic, political, and social impacts of bioterrorism.<br />

BTMN (Biotechnology Management)<br />

BTMN 632 Commercializing Biotechnology in Early-Stage<br />

Ventures (3)<br />

(Formerly BIOT 641.) An overview of the methods for planning<br />

and organizing biotechnology ventures. The elements of a business<br />

plan are considered, as are methods for assessing various<br />

needs, such as capital, personnel, technology, and marketing.<br />

Emphasis is on approaches to marketing technology and<br />

developing joint ventures. The advantages and disadvantages<br />

of forming international ventures are weighed. Discussion also<br />

covers the importance of maintaining relations with external<br />

constituents and the need for managing public awareness.<br />

BTMN 634 Selection and Evaluation of Biotechnology<br />

Projects (3)<br />

A study of the applications of methodologies of technology<br />

forecasting, technology assessment, project management, and<br />

data auditing to the selection and evaluation of biotechnology<br />

projects. The underlying rationale, principles, procedures, and<br />

cost effectiveness of data auditing are examined. A systems<br />

approach to performance evaluation is presented.<br />

BTMN 636 Biotechnology and the Regulatory Environment (3)<br />

A comprehensive review of the role of regulation in biotechnology<br />

products and services development and commercialization.<br />

Emphasis is on the roles of the federal government, state<br />

government agencies, international bodies, and professional<br />

groups, especially the regulatory roles of the U.S. Environmental<br />

Protection Agency, Department of Agriculture, and Food<br />

and Drug Administration. Discussion covers human subject<br />

protection, good laboratory practices, and good manufacturing<br />

practices.<br />

BTMN 670 Capstone in Biotechnology (3)<br />

Prerequisite: Completion of 30 credits, including all other<br />

program core courses. The application of knowledge gained<br />

from previous study to real-world business, technical, and ethical<br />

issues. Topics include entrepreneurship and new venture<br />

creation, progress in biotechnology and prediction of future<br />

trends, and ethical development and management. Discussion<br />

also covers professional goals and an action plan to put knowledge<br />

and experience gained in the program to use. Focus is on<br />

demonstrating analytical, communication, and leadership skills<br />

through case analysis of promising technologies and teamwork<br />

via group development of a strategic product development plan<br />

for a start-up biotechnology venture.<br />

96<br />

GRADUATE CATALOG | <strong>2016–2017</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!